Solid-phase synthesis and biological evaluation of peptides ADP-ribosylated at histidine
dc.contributor.author | Minnee, H | |
dc.contributor.author | Rack, JGM | |
dc.contributor.author | van der Marel, GA | |
dc.contributor.author | Overkleeft, HS | |
dc.contributor.author | Codée, JDC | |
dc.contributor.author | Ahel, I | |
dc.contributor.author | Filippov, DV | |
dc.date.accessioned | 2024-07-18T10:29:21Z | |
dc.date.issued | 2023-10-30 | |
dc.date.updated | 2024-07-17T09:51:35Z | |
dc.description.abstract | The transfer of an adenosine diphosphate (ADP) ribose moiety to a nucleophilic side chain by consumption of nicotinamide adenine dinucleotide is referred to as ADP-ribosylation, which allows for the spatiotemporal regulation of vital processes such as apoptosis and DNA repair. Recent mass-spectrometry based analyses of the "ADP-ribosylome" have identified histidine as ADP-ribose acceptor site. In order to study this modification, a fully synthetic strategy towards α-configured N(τ)- and N(π)-ADP-ribosylated histidine-containing peptides has been developed. Ribofuranosylated histidine building blocks were obtained via Mukaiyama-type glycosylation and the building blocks were integrated into an ADP-ribosylome derived peptide sequence using fluorenylmethyloxycarbonyl (Fmoc)-based solid-phase peptide synthesis. On-resin installation of the ADP moiety was achieved using phosphoramidite chemistry, and global deprotection provided the desired ADP-ribosylated oligopeptides. The stability under various chemical conditions and resistance against (ADP-ribosyl) hydrolase-mediated degradation has been investigated to reveal that the constructs are stable under various chemical conditions and non-degradable by any of the known ADP-ribosylhydrolases. | en_GB |
dc.description.sponsorship | Medical Research Council (MRC) | en_GB |
dc.description.sponsorship | Wellcome Trust | en_GB |
dc.description.sponsorship | Biotechnology and Biological Sciences Research Council (BBSRC) | en_GB |
dc.description.sponsorship | Cancer Research UK | en_GB |
dc.description.sponsorship | Ovarian Cancer Research Alliance | en_GB |
dc.description.sponsorship | National Institute for Health and Care Research (NIHR) | en_GB |
dc.identifier.citation | Vol. 63, No. 4, article e202313317 | en_GB |
dc.identifier.doi | https://doi.org/10.1002/anie.202313317 | |
dc.identifier.grantnumber | MR/N006364/2 | en_GB |
dc.identifier.grantnumber | MR/V033417/1 | en_GB |
dc.identifier.grantnumber | MR/X007472/1 | en_GB |
dc.identifier.grantnumber | 210634 | en_GB |
dc.identifier.grantnumber | 223107 | en_GB |
dc.identifier.grantnumber | BB/R007195/1 | en_GB |
dc.identifier.grantnumber | BB/W016613/1 | en_GB |
dc.identifier.grantnumber | C35050/A22284 | en_GB |
dc.identifier.grantnumber | 813369 | en_GB |
dc.identifier.uri | http://hdl.handle.net/10871/136758 | |
dc.identifier | ORCID: 0000-0001-8341-6439 (Rack, Johannes GM) | |
dc.language.iso | en | en_GB |
dc.publisher | Wiley / Gesellschaft Deutscher Chemiker | en_GB |
dc.relation.url | https://www.ncbi.nlm.nih.gov/pubmed/37903139 | en_GB |
dc.rights | © 2023 The Authors. Angewandte Chemie International Edition published by Wiley-VCH GmbH This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. | en_GB |
dc.subject | ADP-Ribosylation | en_GB |
dc.subject | Glycosylation | en_GB |
dc.subject | Histidine | en_GB |
dc.subject | Peptides | en_GB |
dc.subject | Solid-Phase Synthesis | en_GB |
dc.title | Solid-phase synthesis and biological evaluation of peptides ADP-ribosylated at histidine | en_GB |
dc.type | Article | en_GB |
dc.date.available | 2024-07-18T10:29:21Z | |
dc.identifier.issn | 1433-7851 | |
exeter.place-of-publication | Germany | |
dc.description | This is the final version. Available on open access from Wiley via the DOI in this record. | en_GB |
dc.description | Data Availability Statement: The Supporting Information is available free of charge at: Synthetic procedures for histidine acceptors 3 and 5 and ribosylated building blocks 8-9 and 11-18; protocols for solid-phase peptide synthesis, on-resin phosphorylation, pyrophosphate construction and global deprotection as well as for plasmid expression, protein purification, and (ADPribosyl)hydrolase activity screening; general experimental procedures; and copies of ( 1 H, 13C, HMBC and NOESY) NMR and LC–MS spectra. | en_GB |
dc.identifier.eissn | 1521-3773 | |
dc.identifier.journal | Angewandte Chemie International Edition | en_GB |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | en_GB |
rioxxterms.version | VoR | en_GB |
rioxxterms.licenseref.startdate | 2023-10-30 | |
rioxxterms.type | Journal Article/Review | en_GB |
refterms.dateFCD | 2024-07-18T10:19:17Z | |
refterms.versionFCD | VoR | |
refterms.dateFOA | 2024-07-18T10:29:27Z | |
refterms.panel | A | en_GB |
refterms.dateFirstOnline | 2023-10-30 |
Files in this item
This item appears in the following Collection(s)
Except where otherwise noted, this item's licence is described as © 2023 The Authors. Angewandte Chemie International Edition published by Wiley-VCH GmbH
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.